Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck × Tiragolumab × 90 days × Clear all

NCT05681039 2026-06-02

Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).

Phase 2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT04665843 2026-05-05

SKYSCRAPER-09

Phase 2 Completed

123 enrolled 22 charts

Squamous Cell Carcinoma of Head and Neck